| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,824 |
23,799 |
$1.66M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,905 |
7,032 |
$649K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,300 |
3,284 |
$195K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,213 |
2,146 |
$40K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
599 |
595 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,180 |
3,083 |
$37K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
238 |
238 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
499 |
465 |
$19K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
252 |
252 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
214 |
209 |
$15K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
172 |
166 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
483 |
445 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,033 |
855 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
821 |
802 |
$9K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,231 |
1,817 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
167 |
164 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
630 |
607 |
$6K |
| 90461 |
|
370 |
346 |
$5K |
| 99401 |
|
201 |
189 |
$4K |
| 90658 |
|
261 |
258 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
492 |
488 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,854 |
2,783 |
$3K |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
227 |
225 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
349 |
100 |
$2K |
| 99441 |
|
91 |
90 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
333 |
283 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,030 |
990 |
$1K |
| 94760 |
|
6,660 |
5,939 |
$1K |
| 99442 |
|
44 |
44 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
17 |
$1K |
| 99383 |
|
14 |
14 |
$1K |
| 81002 |
|
647 |
634 |
$1K |
| 99384 |
|
13 |
13 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
31 |
31 |
$850.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,232 |
2,156 |
$442.14 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
39 |
36 |
$318.44 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
49 |
49 |
$75.00 |
| 87400 |
|
296 |
295 |
$68.41 |
| 85018 |
|
372 |
364 |
$60.29 |
| 36410 |
|
44 |
40 |
$28.78 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
49 |
49 |
$25.00 |
| 99051 |
|
14 |
13 |
$24.40 |
| 99000 |
|
4,552 |
4,163 |
$9.00 |
| 99080 |
|
552 |
544 |
$0.00 |
| 90670 |
|
25 |
25 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 90707 |
|
21 |
21 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| 87501 |
|
43 |
41 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
120 |
118 |
$0.00 |
| 90716 |
|
17 |
17 |
$0.00 |